John P. Feighner
John P. Feighner publishes mostly in Psychiatry and Mental health, Pharmacology and Experimental and Cognitive Psychology, on topics such as Treatment of Major Depression, Electroconvulsive Therapy Studies and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes.
- World rank
- #511,189 of 7,710,434 ranked researchers
- Rank in United States
- #177,868 of 1,627,098
- Works
- 111
- Citations
- 12k
- Citations per work
- 110.9
What does John P. Feighner research?
John P. Feighner's work is mostly in Medicine (50%), Psychology (14%), Neuroscience (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5549.8%
- Medicine5549.8%
- Everything else2925.9%
- Social Sciences1513.8%
- Psychology1513.8%
- Life Sciences1210.5%
- 1Psychiatry and Mental health27% of their works
- 2Pharmacology23% of their works
- 3Experimental and Cognitive Psychology11% of their works
- 4Cellular and Molecular Neuroscience7% of their works
- 5Molecular Biology3% of their works
- 6Clinical Psychology3% of their works
Research topics
- Treatment of Major Depression
- Electroconvulsive Therapy Studies
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Bipolar Disorder and Treatment
- Neurotransmitter Receptor Influence on Behavior
- Schizophrenia research and treatment
- Attention Deficit Hyperactivity Disorder
- Mental Health Research Topics
Which keywords describe John P. Feighner's research?
The keywords of their largest research topics: Depression, Antidepressant, Ketamine, Neurobiology, Prevalence, Electroconvulsive Therapy, Serotonin Syndrome and Anxiety Disorders.
- Network Analysis
- ADHD
- Neurocognitive Deficits
- Antipsychotic Drugs
- Bipolar Spectrum Disorder
- Anxiety Disorders
- Electroconvulsive Therapy
- Neurobiology
- Antidepressant
- Depression
- Ketamine
- Prevalence
- Serotonin Syndrome
- Cognitive-Behavioral Therapy
- Treatment Guidelines
- Dopamine
- Serotonin
- Attention-Deficit/Hyperactivity Disorder
- Psychopathology
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Depression852 topics
- Antidepressant601 topic
- Ketamine601 topic
- Neurobiology272 topics
- Prevalence272 topics
- Electroconvulsive Therapy251 topic
- Serotonin Syndrome251 topic
- Anxiety Disorders221 topic
- Cognitive-Behavioral Therapy221 topic
- Bipolar Spectrum Disorder161 topic
- Treatment Guidelines161 topic
- Antipsychotic Drugs131 topic
- Dopamine131 topic
- Neurocognitive Deficits131 topic
- Serotonin131 topic
- ADHD111 topic
- Attention-Deficit/Hyperactivity Disorder111 topic
- Network Analysis71 topic
- Psychopathology71 topic
Where does John P. Feighner work?
John P. Feighner's main affiliation in the publication record is Octapharma (United States), United States.
How many publications and citations does John P. Feighner have?
OpenAlex counts 111 works and 12,309 citations for John P. Feighner, an h-index of 40, ranking #511,189 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about John P. Feighner. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.